您的位置: 首页 > 农业专利 > 详情页

Heterocyclic compound
专利权人:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
发明人:
Shuhei Ikeda,Tatsuki Koike,Jumpei Aida,Makoto Fushimi,Tomokazu Kusumoto,Hideyuki Sugiyama,Masako Miyazaki,Hidekazu Tokuhara,Yasushi Hattori,Makoto Kamata
申请号:
US15563161
公开号:
US10106556B2
申请日:
2016.03.29
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides a compound having an MAGL inhibitory action, which is expected to be useful as an agent for the prophylaxis or treatment of neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, traumatic brain injury, glaucoma, multiple sclerosis etc.), anxiety disorder, pains (e.g., inflammatory pain, cancerous pain, neurogenic pain etc.), epilepsy, depression and the like.The present invention relates a compound represented by the formula (I):wherein each symbol is as described in the specification,or a salt thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充